GENEVA, Nov. 3 -- SCENIC IMMUNOLOGY B.V. (Matrix ONEScience Park 3011098 XH Amsterdam) filed a patent application (PCT/EP2025/061346) for "QPCTL INHIBITORS" on Apr 25, 2025. With publication no. WO/2025/224308, the details related to the patent application was published on Oct 30, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): EVERS, Bastiaan, SCHEEPSTRA, Marcel, WHITLOCK, Gavin Alistair
Abstract: The current invention relates to QPCTL inhibitors represented by formula (I), and corresponding compositions and uses. Preferably, the inhibitors and compositions are for use in the treatment of ...